Not exact matches
The University of Sheffield's Department of
Oncology and Metabolism conducts world - class
research from basic
clinical and
translational cancer
research to life course
research and basic level biology through to diseases such as diabetes and osteoporosis.
Purpose: The development of the UNC Immuno -
Oncology Patient Centered
Translational Research (IMPACT) Biorepository involves the collection of tumor tissue and blood, as well as data (e.g., demographic,
clinical, questionnaire) from patients attending
Oncology Clinics at UNC Hospital and undergoing immune therapy through participation in a Merck IT trial at UNC.
The Department of
Translational Hematology and
Oncology Research (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patie
Research (THOR) conducts cancer
research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patie
research to develop and make available novel diagnostic tools, targeted therapies and
clinical trials for direct use in patient care.
Dr. Zaks began his industry career at GlaxoSmithKline in the genetics
research group, where he built the
oncology translational medicine team and led
translational research on lapatinib as well as the in - licensing and
clinical development of foretinib.
Thomas Gajewski, MD, PhD, assistant professor of pathology and hematology /
oncology at the University of Chicago Hospitals has been awarded a
Clinical Scientist Award in
Translational Research by the Burroughs Wellcome Fund.
April 18, 2011 Cancer specialist Mark Ratain receives prestigious award from leading
oncology society Mark Ratain, MD, the Leon O. Jacobson Professor of Medicine at the University of Chicago, has been awarded the Translational Research Professorship for 2011 by the American Society for Clinical Oncology's Conquer Cancer Fou
oncology society Mark Ratain, MD, the Leon O. Jacobson Professor of Medicine at the University of Chicago, has been awarded the
Translational Research Professorship for 2011 by the American Society for
Clinical Oncology's Conquer Cancer Fou
Oncology's Conquer Cancer Foundation.
From 2001 - 2010 he was an Assistant Professor of
Oncology at Cornell, where his
research efforts were focused on
clinical and
translational projects involving cancer control and pharmacological validation of new agents.
Dr. Eaton's
clinical and
research interests include ocular toxicology,
translational medicine and ophthalmology, primate ophthalmology, and comparative ocular
oncology.
Graduate training in
translational research may be pursued in a number of fields related to
clinical and basic sciences, including anesthesiology and pain management, behavior, cardiology,
clinical epidemiology and population medicine, dentistry, diagnostic imaging (radiology), large animal internal medicine, large animal surgery,
oncology, ophthalmology, production medicine (ruminant and swine), radiation
oncology, small animal internal medicine, small animal surgery, and theriogenology.